Loading…

Imatinib mesylate for aggressive systemic mastocytosis with long bone osteolysis

Saved in:

Bibliographic Details
Published in:	Journal of the American Academy of Dermatology 2011-07, Vol.65 (1), p.224-226
Main Authors:	Jung, Anja Gunda, MD, Horny, Hans-Peter, MD, Sotlar, Karl, MD, Overbeck, Tobias, MD, Schön, Michael Peter, MD, Lippert, Undine, MD
Format:	Article
Language:	English
Subjects:	Absorptiometry, Photon Administration, Oral Antineoplastic Agents - administration & dosage Benzamides Biological and medical sciences Dermatology Dose-Response Relationship, Drug Drug Administration Schedule Female Follow-Up Studies Humans Imatinib Mesylate Mastocytosis, Systemic - complications Mastocytosis, Systemic - drug therapy Mastocytosis, Systemic - pathology Medical sciences Middle Aged Osteolysis - complications Osteolysis - diagnostic imaging Piperazines - administration & dosage Pyrimidines - administration & dosage Risk Assessment Severity of Illness Index Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!